台湾活生物治疗产品的监管框架和挑战
Shirley Pan1, Jia-Chuan Hsu1, Kuo-Teng Hung1
1Taiwan Food and Drug Administration, Ministry of Health and Welfare, Taipei, Taiwan.
Journal of food and drug analysis
|July 1, 2025
概括
活生物治疗产品 (LBPs) 是含有活微生物的药物. 本文详细介绍了台湾对LBP的监管格局,并将其与国际标准进行比较,以促进创新和确保安全.
科学领域:
- 微生物学和生物技术
- 监管科学 监管科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 活生物治疗产品 (LBPs) 被定义为含有活细菌或酵母的药物,用于治疗.
- 由于微生物群研究的进步,LBP因其在医学和生物技术方面的潜力越来越受认可.
- 越来越需要明确的监管框架来管理LBP的开发和营销.
研究的目的:
- 概述台湾LBP的开发,制造和营销要求.
- 将台湾的LBP法规与美国FDA,EMA,PMDA和ICH等机构的国际标准进行比较.
- 确定台湾LBP的关键监管方面和挑战.
主要方法:
- 对LBP相关法规和指导方针的文献综述.
- 分析台湾的监管要求,包括定义,质量,制造,临床证据,标签和营销后监督.
- 对台湾法规与国际基准进行比较分析.
主要成果:
- 台湾将LBP归类为需要注册的生物药物.
- 台湾的主要监管方面包括定义,质量,制造,临床数据,标签和营销后监督.
- 台湾的法规与国际标准保持一致,但要求对LBP创新有更大的包容性.
结论:
- LBPs具有显著的治疗潜力,需要强有力的监管监督.
- 持续适应法规对于促进创新至关重要,同时确保LBP的安全性和有效性.
- 监管机构,行业和科学界之间的合作对于推动LBP部门的发展至关重要.
相关概念视频
Microorganisms in Medicine and Therapeutics
360
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
360
Drug Regulation
1.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
182
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
182
Drug Control Governance: Regulatory Bodies and Their Impact
257
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
257
Bioequivalence: Overview
1.2K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.2K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K


